FDA expands approval for Pfizer cancer drug Sutent

Published: 16/11/2017
FDA expands approval for Pfizer cancer drug Sutent
Source: FEEDS.REUTERS.COM

(Reuters) - The U.S. Food and Drug Administration on Thursday approved the use of Pfizer Inc's cancer drug Sutent to help prevent kidney cancer from returning following surgical removal of a kidney.

Read more
Related news
Comment